Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.087 | 0.7 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.083 | 0.7 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.1 | 0.7 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |